Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 35 Records) |
| Query Trace: Recurrence and ERBB2[original query] |
|---|
| Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2017 Mar . Pang Jia-Min B, Savas Peter, Fellowes Andrew P, Mir Arnau Gisela, Kader Tanjina, Vedururu Ravikiran, Hewitt Chelsee, Takano Elena A, Byrne David J, Choong David Yh, Millar Ewan Ka, Lee C Soon, O'Toole Sandra A, Lakhani Sunil R, Cummings Margaret C, Mann G Bruce, Campbell Ian G, Dobrovic Alexander, Loi Sherene, Gorringe Kylie L, Fox Stephen |
| Elucidating therapeutic molecular targets in premenopausal Asian women with recurrent breast cancers. NPJ breast cancer 2018 4 19. Yap Yoon-Sim, Singh Angad P, Lim John H C, Ahn Jin-Hee, Jung Kyung-Hae, Kim Jeongeun, Dent Rebecca A, Ng Raymond C H, Kim Sung-Bae, Chiang Derek |
| ERBB2 mutation frequency in lobular breast cancer with pleomorphic histology or high-risk characteristics by molecular expression profiling. Genes, chromosomes & cancer 2019 03 58 (3): 175-185. Christgen Matthias, Bartels Stephan, Radner Martin, Raap Mieke, Rieger Luisa, Christgen Henriette, Gluz Oleg, Nitz Ulrike, Harbeck Nadia, Lehmann Ulrich, Kreipe Ha |
| Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 10 25 (3): 967-976. Audenet François, Isharwal Sumit, Cha Eugene K, Donoghue Mark T A, Drill Esther N, Ostrovnaya Irina, Pietzak Eugene J, Sfakianos John P, Bagrodia Aditya, Murugan Paari, Dalbagni Guido, Donahue Timothy F, Rosenberg Jonathan E, Bajorin Dean F, Arcila Maria E, Hechtman Jaclyn F, Berger Michael F, Taylor Barry S, Al-Ahmadie Hikmat, Iyer Gopa, Bochner Bernard H, Coleman Jonathan A, Solit David |
| LobSig is a multigene predictor of outcome in invasive lobular carcinoma. NPJ breast cancer 2019 7 5 18. McCart Reed Amy E, Lal Samir, Kutasovic Jamie R, Wockner Leesa, Robertson Alan, de Luca Xavier M, Kalita-de Croft Priyakshi, Dalley Andrew J, Coorey Craig P, Kuo Luyu, Ferguson Kaltin, Niland Colleen, Miller Gregory, Johnson Julie, Reid Lynne E, Males Renique, Saunus Jodi M, Chenevix-Trench Georgia, Coin Lachlan, Lakhani Sunil R, Simpson Peter |
| Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23-gene panel with utility for non-invasive diagnosis and risk stratification. BJU international 2019 May . Ward Douglas G, Gordon Naheema S, Boucher Rebecca H, Pirrie Sarah J, Baxter Laura, Ott Sascha, Silcock Lee, Whalley Celina M, Stockton Joanne D, Beggs Andrew D, Griffiths Mike, Abbotts Ben, Ijakipour Hanieh, Latheef Fathimath N, Robinson Robert A, White Andrew J, James Nicholas D, Zeegers Maurice P, Cheng K K, Bryan Richard |
| EGFR-mutant lung adenocarcinoma harboring co-mutational tumor suppressor genes predicts poor prognosis. Journal of cancer research and clinical oncology 2020 May . Zhao Yue, Pan Yunjian, Cheng Chao, Zheng Difan, Zhang Yang, Gao Zhendong, Fu Fangqiu, Li Hang, Zheng Shanbo, Zhuge Lingdun, Mao Hengyu, Kuang Muyu, Tao Xiaoting, Peng Yizhou, Hu Hong, Xiang Jiaqing, Li Yuan, Sun Yihua, Chen Haiqu |
| Genetic alterations in epidermal growth factor receptor-tyrosine kinase inhibitor-naïve non-small cell lung carcinoma. Oncology letters 2020 5 19 (6): 4169-4176. Yamaura Takumi, Muto Satoshi, Mine Hayato, Takagi Hironori, Watanabe Masayuki, Ozaki Yuki, Inoue Takuya, Fukuhara Mitsuro, Okabe Naoyuki, Matsumura Yuki, Hasegawa Takeo, Osugi Jun, Hoshino Mika, Higuchi Mitsunori, Shio Yutaka, Suzuki Hiroyu |
| Novel pathogenic alterations in pediatric and adult desmoid-type fibromatosis - A systematic analysis of 204 cases. Scientific reports 2020 Feb 10 (1): 3368. Trautmann Marcel, Rehkämper Jan, Gevensleben Heidrun, Becker Jessica, Wardelmann Eva, Hartmann Wolfgang, Grünewald Inga, Huss Sebasti |
| Copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy. Scientific reports 2020 12 10 (1): 21562. Soave Armin, Kluwe Lan, Yu Hang, Rink Michael, Gild Philipp, Vetterlein Malte W, Marks Philipp, Sauter Guido, Fisch Margit, Meyer Christian P, Ludwig Tim, Dahlem Roland, Minner Sarah, Pantel Klaus, Steinbach Bettina, Schwarzenbach Hei |
| Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the SOLE Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 10 27 (2): 504-512. Guerini-Rocco Elena, Gray Kathryn P, Fumagalli Caterina, Reforgiato Marta Rita, Leone Isabella, Rafaniello Raviele Paola, Munzone Elisabetta, Kammler Roswitha, Neven Patrick, Hitre Erika, Jerusalem Guy, Simoncini Edda, Gombos Andrea, Deleu Ines, Karlsson Per, Aebi Stefan, Chirgwin Jacquie, Di Lauro Vincenzo, Thompson Alastair, Graas Marie-Pascale, Barber Matthew, Fontaine Christel, Loibl Sibylle, Gavilá Joaquín, Kuroi Katsumasa, Müller Bettina, O'Reilly Seamus, Di Leo Angelo, Goldhirsch Aron, Viale Giuseppe, Barberis Massimo, Regan Meredith M, Colleoni Mar |
| Comprehensive Analysis of Metabolic Genes in Breast Cancer Based on Multi-Omics Data. Pathology oncology research : POR 2021 8 27 1609789. Hua Yu, Gao Lihong, Li Xiao |
| Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population. Annals of medicine 2021 Dec 53 (1): 1358-1369. Wang Liye, Zhai Qinglian, Lu Qianyi, Lee Kaping, Zheng Qiufan, Hong Ruoxi, Wang Shus |
| Comprehensive Molecular and Clinicopathologic Analysis of 200 Pulmonary Invasive Mucinous Adenocarcinomas Identifies Distinct Characteristics of Molecular Subtypes. Clinical cancer research : an official journal of the American Association for Cancer Research 2021 5 27 (14): 4066-4076. Chang Jason C, Offin Michael, Falcon Christina, Brown David, Houck-Loomis Brian R, Meng Fanli, Rudneva Vasilisa A, Won Helen H, Amir Sharon, Montecalvo Joseph, Desmeules Patrice, Kadota Kyuichi, Adusumilli Prasad S, Rusch Valerie W, Teed Sarah, Sabari Joshua K, Benayed Ryma, Nafa Khedoudja, Borsu Laetitia, Li Bob T, Schram Alison M, Arcila Maria E, Travis William D, Ladanyi Marc, Drilon Alexander, Rekhtman Natas |
| Significance of KDM6A mutation in bladder cancer immune escape. BMC cancer 2021 5 21 (1): 635. Chen Xingxing, Lin Xuehua, Pang Guofu, Deng Jian, Xie Qun, Zhang Zhengro |
| DNA damage response as a prognostic indicator in metastatic breast cancer via mutational analysis. Annals of translational medicine 2021 Feb 9 (3): 220. Rong Guohua, Yi Zongbi, Ma Fei, Guan Yanfang, Xu Yaping, Li Lifeng, Xu Bing |
| Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: prevalence of actionable mutations among 380 targeted sequencing analyses. BMC cancer 2021 2 21 (1): 199. Huang Chi-Cheng, Tsai Yi-Fang, Liu Chun-Yu, Chao Ta-Chung, Lien Pei-Ju, Lin Yen-Shu, Feng Chin-Jung, Chiu Jen-Hwey, Hsu Chih-Yi, Tseng Ling-Mi |
| TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer. Cancer medicine 2021 Nov . Grote Isabel, Bartels Stephan, Kandt Leonie, Bollmann Laura, Christgen Henriette, Gronewold Malte, Raap Mieke, Lehmann Ulrich, Gluz Oleg, Nitz Ulrike, Kuemmel Sherko, Zu Eulenburg Christine, Braun Michael, Aktas Bahriye, Grischke Eva-Maria, Schumacher Claudia, Luedtke-Heckenkamp Kerstin, Kates Ronald, Wuerstlein Rachel, Graeser Monika, Harbeck Nadia, Christgen Matthias, Kreipe Ha |
| Liquid Biopsy as a Diagnostic and Prognostic Tool for Women and Female Dogs with Breast Cancer. Cancers 2021 Oct 13 (20): . Colombo Jucimara, Moschetta-Pinheiro Marina Gobbe, Novais Adriana Alonso, Stoppe Bruna Ribeiro, Bonini Enrico Dumbra, Gonçalves Francine Moraes, Fukumasu Heidge, Coutinho Luiz Lehmann, Chuffa Luiz Gustavo de Almeida, Zuccari Debora Aparecida Pires de Camp |
| Liquid Biopsy Cell-free DNA Biomarkers in Patients With Oligometastatic Colorectal Cancer Treated by Ablative Radiotherapy. Anticancer research 2021 Feb 41 (2): 829-834. Nakamura Masaki, Kageyama Shun-Ichiro, Seki Masahide, Suzuki Ayako, Okumura Masayuki, Hojo Hidehiro, Motegi Atsushi, Akimoto Tets |
| Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer. European urology 2022 Aug . Gil-Jimenez Alberto, van Dorp Jeroen, Contreras-Sanz Alberto, van der Vos Kristan, Vis Daniel J, Braaf Linde, Broeks Annegien, Kerkhoven Ron, van Kessel Kim E M, Ribal María José, Alcaraz Antonio, Wessels Lodewyk F A, Seiler Roland, Wright Jonathan L, Mengual Lourdes, Boormans Joost, van Rhijn Bas W G, Black Peter C, van der Heijden Michiel |
| ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2022 7 35 (12): 1804-1811. Grote Isabel, Bartels Stephan, Christgen Henriette, Radner Martin, Gronewold Malte, Kandt Leonie, Raap Mieke, Lehmann Ulrich, Gluz Oleg, Graeser Monika, Kuemmel Sherko, Nitz Ulrike, Harbeck Nadia, Kreipe Hans, Christgen Matthi |
| Comparative analysis of cancer gene mutations using targeted sequencing in matched primary and recurrent gastric cancers after chemotherapy. Genes & genomics 2022 May . Huh Yeon-Ju, Cho Sung-Yup, Cho Min-Sun, Lee Kyoung-Eun, Lee Joo- |
| Genomic Landscape of Actionable Mutations in Primary and Metastatic Tissues of Colon Adenocarcinoma. Cureus 2022 Apr 14 (4): e24175. Yekedüz Emre, Akbulut Hakan, Utkan Güngör, Ürün Yüks |
| ERBB2 Mutations as Potential Predictors for Recurrence in Colorectal Serrated Polyps by Targeted Next-Generation Sequencing. Frontiers in oncology 2022 4 12 769709. Wang Qi-Wen, Wang Xin-Yuan, Zhang Qing-Wei, Chen Jin-Nan, Zhou Yu-Jie, Tang Zhao-Rong, Wang Rui-Lan, Chen Haoyan, Chen Huimin, Li Xiao- |
| Genomic characterization and tumor evolution in paired samples of metaplastic breast carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2022 2 35 (8): 1066-1074. Stradella Agostina, Gargallo Pablo, Cejuela Mónica, Petit Anna, Bosch-Schips Jan, Carbonell Paula, Recalde Sabela, Vethencourt Andrea, Fernandez-Ortega Adela, Falo Catalina, Gil-Gil Miguel, Vázquez Silvia, Obadia Verónica, Villanueva-Vázquez Rafael, Soler-Monsó Teresa, Calabria Inés, Pernas Son |
| Association of Pathway Mutations With Survival in Taiwanese Breast Cancers. Frontiers in oncology 2022 12 819555. Yang Po-Sheng, Chao Ying-Ting, Lung Chun-Fan, Liu Chien-Liang, Chang Yuan-Ching, Li Ker-Chau, Hsu Yi-Chiu |
| EGFR co-mutation is associated with the risk of recurrence in invasive lung adenocarcinoma with the micropapillary component. Asian journal of surgery 2023 8 . Haixin Kang, Haiyan Lv, Tao-Hsin Tung, Dehua Ma, Zheng Wang, Juping Du, Kai Zhou, Juan Pan, Yanjie Zhang, Shuotao Peng, Zhaonan Yu, Bo Shen, Minhua |
| Significance of the FGFR3 mutation in Chinese patients with bladder cancer. Translational andrology and urology 2023 6 12 (5): 761-769. Lanxiang Hao, Jiang Fang, Ran Xu, Shuo Liu, Guangcheng Luo, Xinjun Wa |
| ROS1 as a possible prognostic biomarker of cervical adenocarcinoma: An exploratory analysis with next-generation sequencing. Gynecologic oncology 2023 2 171 59-66. Machida Hiroko, Matsuo Koji, Tanaka Masayuki, Kitatani Kanae, Takase Akinori, Yokoyama Keiko, Kajiwara Hiroshi, Yasaka Miwa, Ikeda Masae, Yoshida Hiroshi, Hirasawa Takeshi, Mikami Mik |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: